PGIMER Cancer Research Project Job With Rs. 56,000 pm Pay – Apply Online
Department of Biochemistry, PGIMER, Chandigarh
No. PGI/Biochem/2024/220 (FTS: 145) 23.1.2024
Notice
A Project Research Scientist-I (Non-Medical) is required in the research project entitled, “Diagnostic trial of novel in-house developed Circulating Tumor Cells detection technique for Head and Neck Squamous Cell Carcinoma” funded by ICMR, New Delhi, in Department of Biochemistry, PGIMER, Chandigarh.
Interested candidates are requested to send a detailed CV along with testimonials to the undersigned through the google form link below. The duration of the project will be initially for one year and likely to be extended for three years.
Essential qualification:
- First class Post Graduate degree, including an integrated PG degree
- Second class Post Graduate Degree, including the integrated PG degrees, with PhD and three Years Experience.
Desirable: Experiences in cancer biology, preferably in cell sorting and CTC isolation
Age: 35 years
Salary/Stipend: Rs. 56,000/- + HRA @18%
How to Apply:
Last date of submission of CV: February 2nd, 2024, by 4.00 pm through the google form
Tentative date and Venue of Interview: February 7th, 2024, at 3.00 pm in Deptt. of Biochemistry, 3rd floor, Research Block-A, PGIMER, Chandigarh
Only shortlisted candidates will be
communicated through e-mail by February 4th. No TA/DA will be given for attending the interview.Interested candidates may contact the undersigned for any other query/scientific details of the project through e-mail [email protected] or visit www.lab320pgi.com.
Keywords: PGIMER Cancer Project Job, Project Research Scientist-I, Non-Medical, Department of Biochemistry, Chandigarh, Cancer biology, CTC isolation, Circulating Tumor Cells, ICMR funded project, Apply online, CV submission, Interview date. PGIMER Cancer Research Project Job With Rs. 56,000 pm Pay – Apply Online. Please ensure you are subscribed to the Biotecnika Times Newsletter and our YouTube channel to be notified of the latest industry news. Follow us on social media like Twitter, Telegram, Facebook